These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17100242)

  • 21. [Short-term effect of nebivolol on the left ventricular diastolic function].
    Demiralp E; Kardeşoğlu E; Celik T; Cebeci BS; Ozmen N; Işilak Z; Ulusoy RE; Dinçtürk M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):323-36. PubMed ID: 15590361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of nebivolol on the level of constitutional, inducible, and total NO-synthase in serum of patients with type II diabetes mellitus].
    Mohyl'nyts'ka LA; Man'kovs'kyĭ BM
    Lik Sprava; 2002; (8):123-6. PubMed ID: 12669563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebivolol and endothelium dysfunction in salt-sensitive Dahl rats.
    van Zwieten PA
    J Hypertens; 2002 Mar; 20(3):357. PubMed ID: 11875295
    [No Abstract]   [Full Text] [Related]  

  • 26. Arterial stiffness, hypertension, and rational use of nebivolol.
    Agabiti-Rosei E; Porteri E; Rizzoni D
    Vasc Health Risk Manag; 2009; 5(1):353-60. PubMed ID: 19475771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring vascular benefits of endothelium-derived nitric oxide.
    Cockcroft JR
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of nebivolol on microcirculation, platelet aggregation and blood viscosity in patients with essential hypertension].
    Zadionchenko VS; Sandomirskaia AP; Adasheva TV; Gorbacheva EV; Matveev DV; Mareeva AP; Buval'tsev VI
    Kardiologiia; 2002; 42(5):14-8. PubMed ID: 12494141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of nebivolol on endothelial dysfunction in salt-sensitive hypertension.
    Ugrekhelidze J; Simonia G; Andronikashvili I; Kutateladze M
    Georgian Med News; 2006 Apr; (133):56-8. PubMed ID: 16705229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
    Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nebivolol treatment in essential arterial hypertension].
    Ghiuru R; Rezuş C; Ambăruş V; Ionescu S; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):756-9. PubMed ID: 12092233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of nebivolol on the state of pituitary-gonadal system and lipid peroxidation in young and middle aged men with hypertension].
    Rakhmatullaeva MD
    Kardiologiia; 2003; 43(2):53-5. PubMed ID: 12891274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasodilatory mechanisms of beta receptor blockade.
    Rath G; Balligand JL; Dessy C
    Curr Hypertens Rep; 2012 Aug; 14(4):310-7. PubMed ID: 22639015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress.
    Merchant N; Rahman ST; Ferdinand KC; Haque T; Umpierrez GE; Khan BV
    J Hum Hypertens; 2011 Mar; 25(3):196-202. PubMed ID: 20376076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
    Vyssoulis GP; Marinakis AG; Aznaouridis KA; Karpanou EA; Arapogianni AN; Cokkinos DV; Stefanadis CI
    Am J Hypertens; 2004 Jul; 17(7):582-9. PubMed ID: 15233977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antihypertensive efficacy and tolerability of nebivolol].
    Kirichenko AA; Mironova EV
    Kardiologiia; 2002; 42(12):35-7. PubMed ID: 12494015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.